Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29158011

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Jan
First author
Colleoni M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9.
    note
    Source null
    related pmid
    29158010
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Feb;19(2):e77. doi: 10.1016/S1470-2045(18)30028-7.
    note
    Source null
    related pmid
    29413478
    relationship
    Comment in

Authors and identifiers

  1. name
    Colleoni M
    type
    Author
  2. name
    Luo W
    type
    Author
  3. name
    Karlsson P
    type
    Author
  4. name
    Chirgwin J
    type
    Author
  5. name
    Aebi S
    type
    Author
  6. name
    Jerusalem G
    type
    Author
  7. name
    Neven P
    type
    Author
  8. name
    Hitre E
    type
    Author
  9. name
    Graas MP
    type
    Author
  10. name
    Simoncini E
    type
    Author
  11. name
    Kamby C
    type
    Author
  12. name
    Thompson A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Colleoni M
    type
    Author
  2. name
    Luo W
    type
    Author
  3. name
    Karlsson P
    type
    Author
  4. name
    Chirgwin J
    type
    Author
  5. name
    Aebi S
    type
    Author
  6. name
    Jerusalem G
    type
    Author
  7. name
    Neven P
    type
    Author
  8. name
    Hitre E
    type
    Author
  9. name
    Graas MP
    type
    Author
  10. name
    Simoncini E
    type
    Author
  11. name
    Kamby C
    type
    Author
  12. name
    Thompson A
    type
    Author
bibliography ids
  1. nci-bib-5c6d3da9e4e431df6ba077bd
book metadata
content sha256
19cd50c957ee89aee9068f3f3241066746b0f9330c3b58a46cadd171ae628b31
document type
citation
dois
  1. 10.1016/S1470-2045(17)30715-5
electronic publication date
display
2017 Nov 17
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29158011
immutable id
pubmed:29158011@19cd50c957ee89aee9068f3f3241066746b0f9330c3b58a46cadd171ae628b31
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
127-138
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9.
    note
    Source null
    related pmid
    29158010
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Feb;19(2):e77. doi: 10.1016/S1470-2045(18)30028-7.
    note
    Source null
    related pmid
    29413478
    relationship
    Comment in
outcomes validated
false
pmid
29158011
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
c4d0064d21624992ab928478476c831f47e40fbb47112619259f3f4c17f5313f
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2018 Jan
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29158011/
title
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Preserved source evidence · Not medical advice